The next chapter of the autism therapy industry’s story will look very different from previous ones. Already, the industry has gone from obscure and mom-and-pop to mainstream and private equity backed. Now, the forces driving the industry require it to do much more than ever before. To some degree, these forces will require the industry […]
The autism therapy industry needs to continue its strategic and cultural evolution. That goes for all its constituents — providers, payers and investors alike. This evolution has been ongoing to varied degrees for years now. The expansion of the industry through private investment accelerated it. Today, the industry must take care to ensure an ethical […]
The autism therapy industry’s many challenges will force the industry to reach greater heights of quality. In addition to the structural challenges the segment faces — stagnant reimbursement rates, workforce challenges, and the like — autism therapy has to reckon with a small yet potent movement against its central offering: applied behavior analysis (ABA). The […]
With some major stumbles in the autism service industry still fresh in public memory, it may seem like an odd time for Gracent LLC to launch a new private equity-backed platform. But Gracent’s leadership says now is the right time to get into the game after seeing where others went wrong. That includes keeping sustainability […]
Industry insiders projected that 2023 would be a year of reckoning for autism treatment providers. The reckoning is here. Major platform companies have made significant stumbles, and workforce challenges still plague the industry. All the while, payers continue to hold out on raising reimbursement rates for most autism therapies. Instead, payers eye value-based care arrangements. […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
